Biogenea Pharmaceuticals Ltd.
Clinical trials sponsored by Biogenea Pharmaceuticals Ltd., explained in plain language.
-
Custom cancer vaccine trial uses 'Quantum' tech to target tumors
Disease control ENROLLING_BY_INVITATIONThis early-phase trial is testing a personalized vaccine for people with high-risk or recurrent endometrial cancer. The vaccine is custom-made for each patient based on the unique genetic markers of their tumor, with the goal of training their immune system to fight the cancer. A…
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
AI designs custom vaccines to fight lung cancer
Disease control ENROLLING_BY_INVITATIONThis early-stage study is testing a personalized vaccine, Microlyvaq™, for people with advanced non-small cell lung cancer (NSCLC). The vaccine is custom-made for each patient using AI to analyze their specific tumor. It is given alongside standard chemotherapy and immunotherapy …
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC